Publications hub
Find our publications, laboratory reports, meeting minutes and statements, and scheduling decisions.
We’re still confirming the best location for some of our content. Can't find what you’re looking for? You can also:
-
search our Resources
-
use the site search bar in the top right of this screen for more results.
Use the filters below to narrow your search.
Filter results
You can narrow down the results using the filters.
Topic
- Advisory bodies and committees (351)
- Scheduling (national classification system) (148)
- Prescription medicines (31)
- Advertising (24)
- In Vitro Diagnostic medical devices (IVDs) (24)
- Medicines safety (19)
- Therapeutic goods regulation (18)
- Medical devices safety (12)
- Manufacturing (11)
- Complementary medicines (9)
- Safety (9)
- Non-prescription medicines (8)
- Over the counter (OTC) medicines (8)
- COVID-19 vaccines (7)
- Listed medicines (7)
- Regulatory compliance (7)
- COVID-19 (6)
- Assessed listed medicines (5)
- Medicinal cannabis hub (5)
- Registered complementary medicines (5)
- Shortages (4)
- Fees and payments (3)
- Legislation (3)
- Alert/Advisory (2)
- Import and export (2)
- Artificial Intelligence (AI) (1)
- Australian Register of Therapeutic Goods (ARTG) (1)
- Biological medicines (1)
- Breast implant hub (1)
- Clinical trials (1)
- Compliance and enforcement hub (1)
- Cosmetics (1)
- Disinfectants/Sterilants (1)
- Labelling and packaging (1)
- Metal-on-metal hip replacement implants hub (1)
- Pharmacovigilance (1)
- Prescription opioids hub (1)
- Sunscreens (1)
Results for
"[search-keyword]"
Search
688 result(s) found, displaying 26 to 50
-
PublicationsThis Cost Recovery Implementation Statement (CRIS) 2024-2025 provides information on how we implement, and cost recover our regulatory activities.
-
Meeting statementsCommunique from the 6th meeting of the WHPWG, 27 March 2024
-
TGA laboratory testing reportsMedicinal cannabis products are permitted to be supplied into Australia under the Special Access Scheme, by authorised prescribers, and/or for use in clinical trials.
-
Meeting statementsAdvisory Committee on Vaccines meeting statement for meeting 47, held on 31 January 2024.
-
Meeting statementsAdvisory Committee on Vaccines meeting statement for meeting 48 held on 1 May 2024.
-
PublicationsThis framework outlines our processes to identify and manage risk relating to breast implants.
-
PublicationsThis fact sheet is for healthcare practitioners to help understand the rules surrounding importation of cosmetic injectables.
-
Scheduling decisions (final)This publication is a notice of decision made by a delegate of the Secretary of the Department of Health and Aged Care under section 52D(2) of the Therapeutic Goods Act 1989, and the reasons for the decision.
-
PublicationsThe report cards show the progress made by the TGA in the 3 strategies that make up the Action Plan for Medical Devices.
-
Scheduling decisions (final)Read our notice of final decision to amend (or not amend) the current Poisons Standard
-
PublicationsFind out about the seasonal influenza vaccines available for the 2024 southern hemisphere season.
-
Meeting statementsRead the meeting statement from 18 April 2024 meeting of the Advisory Committee on Medical Devices (ACMD).
-
Meeting statementsA meeting statement from the Medical Devices Allied Health Sector Working Group is now available.
-
Meeting statementsA meeting statement from the Point-of-care Manufacturing of Medical Devices Complex Manufacturing Hubs in Healthcare Facilities Working Group is now available.
-
Scheduling decisions (final)Final decision on proposed amendments to the Poisons Standard relating to bromoxynil
-
Meeting statementsA meeting statement from the Dental Sector Working Group is now available.
-
Meeting statementsA meeting statement from the first meeting of the Point-of-care Manufacturing of Medical Devices Steering Committee is now available.
-
Scheduling submissionsFind out about the public submissions on interim decisions for scheduling matters referred to the ACMS #43, ACCS #37 and Joint ACMS-ACCS #35 meetings held in November 2023
-
PublicationsThis plan outlines the compliance and education priorities of the Therapeutic Goods Administration for 2024.
-
Scheduling decisions (interim)Interim decisions and invitation for further comment. Closing date: 17 April 2024
-
Meeting statementsRead key points of discussion from the meeting 13 of the Medical Devices Consumer Working Group (MDCWG).
-
Meeting statementsRead the meeting statement from 8 February 2024 meeting of the Advisory Committee on Medical Devices (ACMD).
-
Meeting statementsRead the meeting statement from 7 December 2023 meeting of the Advisory Committee on Medical Devices (ACMD).
-
Meeting statementsRead the meeting statement from 12 October 2023 meeting of the Advisory Committee on Medical Devices (ACMD).
-
Meeting statementsCommunique from the meeting of the TGACC